SomaLogic, Inc.

CM Life Sciences III Inc., trading under ticker CMII, was a blank-check company sponsored by CM Life Sciences that completed its initial public offering in 2021 with a focus on the life sciences and healthcare sector. The SPAC subsequently completed a business combination with SomaLogic, Inc., a proteomics company specializing in large-scale protein measurement technology. An 8-K was filed with the SEC on December 21, 2023, under accession number 0001104659-23-128312, reflecting a material disclosure by the combined company operating as SomaLogic, Inc. following the close of the de-SPAC transaction. Visit SpacDesk and sign up for full access to CMII filings, timeline data, and sponsor analytics.